Skip to menu Skip to content Skip to footer

2014

Conference Publication

Eculizumab Is Effective Therapy for Atypical Haemolytic Uraemic Syndrome (Ahus): a Case Series of Australian Patients

Mallett, A., Campbell, S., Van Eps, C., Hawley, C., Burke, J., Hughes, P., Kausman, J., Hewitt, I., Parnham, A., Szer, J., Tuckfield, A., Payne, S., Young, J. and Isbel, N. (2014). Eculizumab Is Effective Therapy for Atypical Haemolytic Uraemic Syndrome (Ahus): a Case Series of Australian Patients. WILEY-BLACKWELL.

Eculizumab Is Effective Therapy for Atypical Haemolytic Uraemic Syndrome (Ahus): a Case Series of Australian Patients

2014

Conference Publication

Protein Bound Uremic Toxins and Cardiovascular Disease: An Observational Study Across the Ckd Spectrum

Rossi, M., Campbell, K. L., Johnson, D. W., Stanton, T., Pascoe, E. M., Hawley, C. M., Dimeski, G., Mcwhinney, B. C., Ungerer, J. P. and Isbel, N. M. (2014). Protein Bound Uremic Toxins and Cardiovascular Disease: An Observational Study Across the Ckd Spectrum. 50th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Melbourne, Australia, 25–27 August 2014. HOBOKEN: Wiley.

Protein Bound Uremic Toxins and Cardiovascular Disease: An Observational Study Across the Ckd Spectrum

2014

Conference Publication

Research priorities in chronic kidney disease: a priority setting partnership

Tong, A., Crowe, S., Chando, S., Cass, A., Chadban, S. J., Chapman, J. R., Gallagher, M., Gillis, J., Hawley, C., Hill, S., Howard, K., Johnson, D. W., Kerr, P., Mathew, T., Mckenzie, A., Parker, D., Polkinghorne, K., Perkovic, V., Pollock, C., Strippoli, G. F. M., Tugwell, P., Walker, R. G., Webster, A. C., Wilson, A., Wong, G. and Craig, J. C. (2014). Research priorities in chronic kidney disease: a priority setting partnership. 50th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Melbourne, Australia, 25-27 August 2014. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia.

Research priorities in chronic kidney disease: a priority setting partnership

2014

Journal Article

Establishing a clinical trials network in nephrology: Experience of the Australasian Kidney Trials Network

Morrish, A.T., Hawley, C.M., Johnson, D.W., Badve, S.V., Perkovic, V., Reidlinger, D.M. and Cass, A. (2014). Establishing a clinical trials network in nephrology: Experience of the Australasian Kidney Trials Network. Kidney International, 85 (1), 23-30. doi: 10.1038/ki.2013.391

Establishing a clinical trials network in nephrology: Experience of the Australasian Kidney Trials Network

2014

Conference Publication

Volumetric bone mineral density (vBMD) and functional bone-muscle unit assessment with peripheral quantitative computed tomography(pQCT) in patients with chronic kidney disease (CKD) state 4 and 5

Krisnasamy, R., Isbel, N. M., Johnson, D. W., Campbell, S. B., Mudge, D. W., Van Eps, C. L., Fiumara, F., Bolwell, J., Stanton, T. and Hawley, C. M. (2014). Volumetric bone mineral density (vBMD) and functional bone-muscle unit assessment with peripheral quantitative computed tomography(pQCT) in patients with chronic kidney disease (CKD) state 4 and 5. 50th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Melbourme, VIC Australia, 25-27 August 2014. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/nep.12301

Volumetric bone mineral density (vBMD) and functional bone-muscle unit assessment with peripheral quantitative computed tomography(pQCT) in patients with chronic kidney disease (CKD) state 4 and 5

2014

Conference Publication

LIVE DONOR STUDY - IMPACT OF KIDNEY DONATION ON LP(a) AND OTHER LIPIDS AT ONE YEAR POST LIVE DONOR NEPHRECTOMY

Doucet, B., Kostner, K., Hawley, C. and Isbel, N. (2014). LIVE DONOR STUDY - IMPACT OF KIDNEY DONATION ON LP(a) AND OTHER LIPIDS AT ONE YEAR POST LIVE DONOR NEPHRECTOMY. WILEY-BLACKWELL.

LIVE DONOR STUDY - IMPACT OF KIDNEY DONATION ON LP(a) AND OTHER LIPIDS AT ONE YEAR POST LIVE DONOR NEPHRECTOMY

2014

Journal Article

The association between left ventricular global longitudinal strain, renal impairment and all-cause mortality

Krishnasamy, Rathika, Isbel, Nicole M., Hawley, Carmel M., Pascoe, Elaine M., Leano, Rodel, Haluska, Brian A. and Stanton, Tony (2014). The association between left ventricular global longitudinal strain, renal impairment and all-cause mortality. Nephrology Dialysis Transplantation, 29 (6), 1218-1225. doi: 10.1093/ndt/gfu004

The association between left ventricular global longitudinal strain, renal impairment and all-cause mortality

2014

Journal Article

Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): A randomised trial

Johnson, David W., Badve, Sunil V., Pascoe, Elaine M., Beller, Elaine, Cass, Alan, Clark, Carolyn, de Zoysa, Janak, Isbel, Nicole M., McTaggart, Steven, Morrish, Alicia T., Playford, E. Geoffrey, Scaria, Anish, Snelling, Paul, Vergara, Liza A., Hawley, Carmel M. and for the HONEYPOT Study Collaborative Group (2014). Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): A randomised trial. The Lancet Infectious Diseases, 14 (1), 23-30. doi: 10.1016/S1473-3099(13)70258-5

Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): A randomised trial

2014

Journal Article

Clinical causes of inflammation in peritoneal dialysis patients

Cho, Yeoungjee, Hawley, Carmel M. and Johnson, David W. (2014). Clinical causes of inflammation in peritoneal dialysis patients. International Journal of Nephrology, 2014 909373, 909373-9. doi: 10.1155/2014/909373

Clinical causes of inflammation in peritoneal dialysis patients

2014

Conference Publication

The effect of pentoxifylline on oxidative stress markers: substudy of the hero trial

Zhang, L., Pascoe, E. M., Badve, S. V., Cass, A., Clarke, P., Coombes, J. S., Ferrari, P., Mcdonald, S. P., Morrish, A. T., Pedagogos, E., Perkovic, V., Reidlinger, D., Scaria, A., Walker, R., Vergara, L. A., Hawley, C. M. and Johnson, D. W. (2014). The effect of pentoxifylline on oxidative stress markers: substudy of the hero trial. 50th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Melbourne, VIC, Australia, 25-27 August 2014. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/nep.12301

The effect of pentoxifylline on oxidative stress markers: substudy of the hero trial

2013

Journal Article

Protein-bound uremic toxins, inflammation and oxidative stress: A cross-sectional study in stage 3-4 chronic kidney disease

Rossi, M., Campbell, K.L., Johnson, D.W., Stanton, T., Vesey, D.A., Coombes, J.S., Weston, K.S., Hawley, C.M., McWhinney, B.C., Ungerer, J.P.J. and Isbel, N. (2013). Protein-bound uremic toxins, inflammation and oxidative stress: A cross-sectional study in stage 3-4 chronic kidney disease. Archives of Medical Research, 45 (4), 309-317. doi: 10.1016/j.arcmed.2014.04.002

Protein-bound uremic toxins, inflammation and oxidative stress: A cross-sectional study in stage 3-4 chronic kidney disease

2013

Journal Article

Estimated GFR reporting influences recommendations for dialysis initiation

Brimble, K. Scott, Mehrotra, Rajnish, Tonelli, Marcello, Hawley, Carmel M., Castledine, Clare, McDonald, Stephen P., Levidiotis, Vicki, Gangji, Azim S., Treleaven, Darin J., Margetts, Peter J. and Walsh, Michael (2013). Estimated GFR reporting influences recommendations for dialysis initiation. Journal of the American Society of Nephrology, 24 (11), 1737-1742. doi: 10.1681/ASN.2013010035

Estimated GFR reporting influences recommendations for dialysis initiation

2013

Journal Article

Is Alpha-B Crystallin an Independent Marker for Prognosis in Lung Cancer?

Campbell-Lloyd, Andrew J. M., Mundy, Julie, Deva, Rajeev, Lampe, Guy, Hawley, Carmel, Boyle, Glen, Griffin, Rayleene, Thompson, Charles and Shah, Pallav (2013). Is Alpha-B Crystallin an Independent Marker for Prognosis in Lung Cancer?. Heart Lung and Circulation, 22 (9), 759-766. doi: 10.1016/j.hlc.2013.01.014

Is Alpha-B Crystallin an Independent Marker for Prognosis in Lung Cancer?

2013

Journal Article

Association of biocompatible peritoneal dialysis solutions with peritonitis risk, treatment, and outcomes

Cho, Yeoungjee, Badve, Sunil V., Hawley, Carmel M., McDonald, Stephen P., Brown, Fiona G., Boudville, Neil, Bannister, Kym M., Clayton, Philip A. and Johnson, David W. (2013). Association of biocompatible peritoneal dialysis solutions with peritonitis risk, treatment, and outcomes. Clinical Journal of the American Society of Nephrology, 8 (9), 1556-1563. doi: 10.2215/CJN.12361212

Association of biocompatible peritoneal dialysis solutions with peritonitis risk, treatment, and outcomes

2013

Journal Article

Interventions for erythropoietin-resistant anaemia in dialysis patients (Review)

Badve Sunil V., Beller, Elaine M., Cass, Alan, Francis, Daniel P., Hawley, Carmel, Macdougall, Iain C., Perkovic, Vlado and Johnson, David W. (2013). Interventions for erythropoietin-resistant anaemia in dialysis patients (Review). Cochrane Database of Systematic Reviews, 2013 (8) CD006861. doi: 10.1002/14651858.CD006861.pub3

Interventions for erythropoietin-resistant anaemia in dialysis patients (Review)

2013

Journal Article

The HONEYPOT randomized controlled trial: statistical analysis plan

Pascoe, Elaine Mary, Lo, Serigne, Scaria, Anish, Badve, Sunil V., Beller, Elaine Mary, Cass, Alan, Hawley, Carmel Mary and Johnson, David W. (2013). The HONEYPOT randomized controlled trial: statistical analysis plan. Peritoneal Dialysis International, 33 (4), 426-435. doi: 10.3747/pdi.2012.00310

The HONEYPOT randomized controlled trial: statistical analysis plan

2013

Journal Article

Vitamin D does not improve the metabolic health of patients with chronic kidney disease stage 3-4: A randomized controlled trial (vol 18, pg 26, 2013)

Petchey, William G., Hickman, Ingrid J., Prins, Johannes B., Hawley, Carmel M., Johnson, David W., Isabel, Nicole M. and Duncan, Emma L. (2013). Vitamin D does not improve the metabolic health of patients with chronic kidney disease stage 3-4: A randomized controlled trial (vol 18, pg 26, 2013). Nephrology, 18 (6), 481-481. doi: 10.1111/nep.12095

Vitamin D does not improve the metabolic health of patients with chronic kidney disease stage 3-4: A randomized controlled trial (vol 18, pg 26, 2013)

2013

Journal Article

The outcomes of patients with ESRD and ANCA-associated Vasculitis in Australia and New Zealand

Tang, Wen, Bose, Bhadran, McDonald, Stephen P., Hawley, Carmel M., Badve, Sunil V., Boudville, Neil, Brown, Fiona G., Clayton, Philip A., Campbell, Scott B., Peh, Chen Au and Johnson, David W. (2013). The outcomes of patients with ESRD and ANCA-associated Vasculitis in Australia and New Zealand. Clinical Journal of the American Society of Nephrology, 8 (5), 773-780. doi: 10.2215/CJN.08770812

The outcomes of patients with ESRD and ANCA-associated Vasculitis in Australia and New Zealand

2013

Journal Article

Anti-glomerular basement membrane antibody disease is an uncommon cause of end-stage renal disease

Tang, Wen, McDonald, Stephen P., Hawley, Carmel M., Badve, Sunil V., Boudville, Neil C., Brown, Fiona G., Clayton, Philip A., Campbell, Scott B., de Zoysa, Janak R. and Johnson, David W. (2013). Anti-glomerular basement membrane antibody disease is an uncommon cause of end-stage renal disease. Kidney International, 83 (3), 503-510. doi: 10.1038/ki.2012.375

Anti-glomerular basement membrane antibody disease is an uncommon cause of end-stage renal disease

2013

Journal Article

End-stage renal failure due to amyloidosis: outcomes in 490 ANZDATA registry cases

Tang, Wen, McDonald, Stephen P., Hawley, Carmel M., Badve, Sunil V., Boudville, Neil, Brown, Fiona G., Clayton, Philip A., Campbell, Scott B., de Zoysa, Janak R. and Johnson, David W. (2013). End-stage renal failure due to amyloidosis: outcomes in 490 ANZDATA registry cases. Nephrology Dialysis Transplantation, 28 (2), 455-461. doi: 10.1093/ndt/gfs492

End-stage renal failure due to amyloidosis: outcomes in 490 ANZDATA registry cases